thyroxine has been researched along with Hyperlipemia in 149 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Subclinical hypothyroidism (SCH) has been associated with increased carotid intima-media thickness (C-IMT) in recent studies, but the effects of levothyroxine (L-T4) therapy on C-IMT in SCH patients are still controversial." | 8.95 | Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. ( Chen, B; Shan, Z; Wang, H; Wang, X; Zhang, Y; Zhao, T; Zhou, Y, 2017) |
| "Bexarotene is an oral retinoid therapy that is effective for the treatment of early and advanced-stage cutaneous T-cell lymphoma (CTCL) in patients who have failed on other therapies." | 8.83 | Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion. ( Assaf, C; Bagot, M; Dummer, R; Duvic, M; Gniadecki, R; Knobler, R; Ranki, A; Schwandt, P; Whittaker, S, 2006) |
| "The familial dysalbuminemic hyperthyroxinemia (FDH) phenotype results from a natural human serum albumin (HSA) mutant with histidine instead of arginine at amino acid position 218." | 7.69 | Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. ( Bhagavan, NV; Ha, CE; Jameson, DM; Petersen, CE, 1996) |
| "Since hyperlipidemia was not improved by pravastatin, atorvastatin or niceritrol, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0." | 5.33 | Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism. ( Kiya, Y; Miura, S; Saku, K; Urata, H; Zhang, B, 2006) |
| "The significance of dyslipidemia in subclinical hypothyroidism (SH) and the effect of thyroid substitution on lipids remain controversial." | 5.31 | Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? ( Bairaktari, ET; Bitsis, S; Efstathiadou, Z; Elisaf, MS; Kukuvitis, A; Milionis, HJ; Tsatsoulis, A, 2001) |
| "To induce hyperlipemia in vitro, IV fat emulsion was diluted in deionized water to produce 0 (water only), 33, 67, or 100% mixtures." | 5.28 | Effects of hyperlipemia on radioimmunoassays for progesterone, testosterone, thyroxine, and cortisol in serum and plasma samples from dogs. ( Lamb, SV; Lee, DE; Reimers, TJ, 1991) |
| "Subclinical hypothyroidism (SCH) has been associated with increased carotid intima-media thickness (C-IMT) in recent studies, but the effects of levothyroxine (L-T4) therapy on C-IMT in SCH patients are still controversial." | 4.95 | Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. ( Chen, B; Shan, Z; Wang, H; Wang, X; Zhang, Y; Zhao, T; Zhou, Y, 2017) |
| "L-thyroxine (LT4) treatment of hypothyroidism, particularly in patients with thyroid- stimulating hormone (TSH) >10mU/L, results in improved lipid profile, as LT4 stimulates low-density lipoprotein cholesterol (LDL-C) degradation and the conversion of cholesterol in bile acids by inducing LDL-receptor and 7 alpha hydroxylase expression, respectively." | 4.93 | Thyroid hormones: a potential ally to LDL-cholesterol-lowering agents. ( Brenta, G; Duntas, LH, 2016) |
| "Bexarotene is an oral retinoid therapy that is effective for the treatment of early and advanced-stage cutaneous T-cell lymphoma (CTCL) in patients who have failed on other therapies." | 4.83 | Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion. ( Assaf, C; Bagot, M; Dummer, R; Duvic, M; Gniadecki, R; Knobler, R; Ranki, A; Schwandt, P; Whittaker, S, 2006) |
| "To determine whether the literature supports an effect of subclinical hypothyroidism on serum lipids and, if so, what are the effects of thyroxine replacement therapy." | 4.82 | Effects of subclinical hypothyroidism and its treatment on serum lipids. ( Ineck, BA; Ng, TM, 2003) |
| "Bexarotene produce as predictable side effects severe mixed hyperlipidemia with marked decrease in HDL-cholesterol levels and central hypothyroidism, being the both reversible and dose-dependent." | 3.83 | [Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma]. ( Garcia Morillo, JS; Muñiz Grijalvo, O; Pamies Andreu, E; Rodriguez Suarez, S, 2016) |
| " Patients with hypothyroidism were identified by means of a computed database, from January 1, 1989, to July 1, 1993, first by levothyroxine sodium medication and second by serum thyrotropin values greater than 5 mU/L." | 3.69 | Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. ( Diekman, T; Kastelein, JJ; Lansberg, PJ; Wiersinga, WM, 1995) |
| "The familial dysalbuminemic hyperthyroxinemia (FDH) phenotype results from a natural human serum albumin (HSA) mutant with histidine instead of arginine at amino acid position 218." | 3.69 | Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. ( Bhagavan, NV; Ha, CE; Jameson, DM; Petersen, CE, 1996) |
| "Concentrations of serum cholesterol, triglyceride, and free glycerol were neasured, and serum lipoprotein electrophoresis was performed in normal dogs and in dogs with hypothyroidism, diabetes mellitus, and acute pancreatitis." | 3.65 | Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoproteinemia. ( Donovan, EF; Kociba, GJ; Rogers, WA, 1975) |
| "Low-T3 syndrome is a strong predictor of death in cardiac patients and might be directly implicated in the poor prognosis of cardiac patients." | 2.71 | Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. ( Donato, L; Iervasi, G; L'Abbate, A; Landi, P; Pingitore, A; Raciti, M; Ripoli, A; Scarlattini, M, 2003) |
| "Halofenate is a new antilipemic drug which is an ester of carboxylic acid." | 2.64 | The metabolic spectrum of halofenate. ( Ryan, JR, 1975) |
| "Bexarotene has been FDA-approved for the treatment of CTCL, but previous studies have been conducted on CD4+ CTL and there have been no reports about its use in CD8+ CTCL." | 2.44 | CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature. ( Abbott, L; Farah, R; Gopaluni, S; Hutchison, R; Perzova, R; Poiesz, BJ; Shrimpton, A, 2008) |
| "The nephrotic syndrome is the only hypoalbuminaemic state frequently associated with hyperlipidaemia." | 2.35 | Biochemical anomalies of the nephrotic syndrome. ( Gabriel, R; Lewith, G, 1975) |
| "Diabetic lipemia, although common in type 2 diabetes, is rare in type 1 diabetes mellitus." | 1.40 | Diabetic lipemia presenting as eruptive xanthomas in a child with autoimmune polyglandular syndrome type IIIa. ( Batra, P; Shah, D; Singhal, R, 2014) |
| "Primary hypothyroidism and type 2 diabetes are both typically associated with the increased level of triglycerides." | 1.33 | A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas. ( Chang, SH; Chung, SI; Hahm, JR; Jung, JH; Jung, TS; Kim, DR; Kim, MA; Lee, GW; Park, JR; Park, KJ, 2005) |
| "Since hyperlipidemia was not improved by pravastatin, atorvastatin or niceritrol, and since the levels of thyroid-stimulating hormone (TSH) and free T4 were 730 IU/ml and 0." | 1.33 | Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism. ( Kiya, Y; Miura, S; Saku, K; Urata, H; Zhang, B, 2006) |
| "Hyperlipidemia is a secondary disorder associated with many metabolic disorders including hypothyroidism." | 1.32 | The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders. ( Abdel-Gayoum, AA; Al-Tonsi, AA; Saad, M, 2004) |
| "Finally, hemolysis and lipemia significantly interfered with cortisol and fT4 measurements, whereas bilirubinemia did not affect the results." | 1.32 | Cortisol and free thyroxine determination by time-resolved fluorometry in canine serum. ( Bernal, LJ; Cerón, JJ; Parra, MD, 2004) |
| "The significance of dyslipidemia in subclinical hypothyroidism (SH) and the effect of thyroid substitution on lipids remain controversial." | 1.31 | Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? ( Bairaktari, ET; Bitsis, S; Efstathiadou, Z; Elisaf, MS; Kukuvitis, A; Milionis, HJ; Tsatsoulis, A, 2001) |
| "To induce hyperlipemia in vitro, IV fat emulsion was diluted in deionized water to produce 0 (water only), 33, 67, or 100% mixtures." | 1.28 | Effects of hyperlipemia on radioimmunoassays for progesterone, testosterone, thyroxine, and cortisol in serum and plasma samples from dogs. ( Lamb, SV; Lee, DE; Reimers, TJ, 1991) |
| "Contrasting clinical pictures of cretinism, which appeared related to age and previous treatment were found with a spectrum ranging from predominantly myxoedematous in the youngest to predominantly neurological in the 16 year old male." | 1.28 | Central cretinism in four successive siblings. ( Das, SC; Egbuta, JO; Isichei, UP, 1990) |
| "Cholesterol induced hyperlipidemia was controlled by garlic feeding." | 1.27 | Hypolipidemic effect of garlic and thyroid function. ( Chakravarty, SK; Chaudhuri, BN; Mongia, SS; Mukherjee, SK, 1984) |
| "In a patient with type II hyperlipemia, the extravascular recycling pathway is reduced and is not corrected with D-thyroxine therapy." | 1.26 | Incorporation of 75Se-selenomethionine into human apoproteins. III. Kinetic behavior of isotopically labeled plasma apoprotein in man. ( Crespin, S; Eaton, RP; Kipnis, DM, 1976) |
| "Combined hyperlipidemia was common (77%), and lipoprotein phenotyping revealed types IIB hyperlipopro-teinemia in 11, IIA in 5, III in 3 and IV in 3 patients." | 1.26 | Hypothyroidism, an important cause of reversible hyperlipidemia. ( Crowther, SM; Mishkel, MA, 1977) |
| "Hyperlipemia is one of several risk factors for premature ischemic vascular disease." | 1.26 | A pathophysiologic approach to managing hyperlipemia. ( Hazzard, WR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 107 (71.81) | 18.7374 |
| 1990's | 17 (11.41) | 18.2507 |
| 2000's | 17 (11.41) | 29.6817 |
| 2010's | 8 (5.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, T | 1 |
| Chen, B | 1 |
| Zhou, Y | 1 |
| Wang, X | 1 |
| Zhang, Y | 1 |
| Wang, H | 1 |
| Shan, Z | 1 |
| Domouzoglou, EM | 1 |
| Fisher, FM | 1 |
| Astapova, I | 1 |
| Fox, EC | 1 |
| Kharitonenkov, A | 1 |
| Flier, JS | 1 |
| Hollenberg, AN | 1 |
| Maratos-Flier, E | 1 |
| Batra, P | 1 |
| Singhal, R | 1 |
| Shah, D | 1 |
| Rodriguez Suarez, S | 1 |
| Pamies Andreu, E | 1 |
| Muñiz Grijalvo, O | 1 |
| Garcia Morillo, JS | 1 |
| Hasanato, R | 1 |
| Brearton, S | 1 |
| Alshebani, M | 1 |
| Bailey, L | 1 |
| Aldugashim, S | 1 |
| Alothaim, A | 1 |
| Tamimi, W | 1 |
| Yang, N | 1 |
| Zhang, DL | 1 |
| Hao, JY | 1 |
| Wang, G | 1 |
| Duntas, LH | 1 |
| Brenta, G | 1 |
| Gopaluni, S | 1 |
| Perzova, R | 1 |
| Abbott, L | 1 |
| Farah, R | 1 |
| Shrimpton, A | 1 |
| Hutchison, R | 1 |
| Poiesz, BJ | 1 |
| Rosario, M | 1 |
| Song, SX | 1 |
| McCullough, LD | 1 |
| Iervasi, G | 1 |
| Pingitore, A | 1 |
| Landi, P | 1 |
| Raciti, M | 1 |
| Ripoli, A | 1 |
| Scarlattini, M | 1 |
| L'Abbate, A | 1 |
| Donato, L | 1 |
| Ineck, BA | 1 |
| Ng, TM | 1 |
| SALA, L | 1 |
| DAVIS, OF | 1 |
| BECK, C | 1 |
| BERGAL, M | 1 |
| SLOAN, N | 1 |
| LEVINE, AJ | 1 |
| BERNHEIM, C | 2 |
| FORSTER, G | 2 |
| LUETHY, E | 1 |
| SHIPP, JC | 1 |
| MUNROE, JF | 1 |
| SOULAIRAC, A | 1 |
| CAHN, J | 1 |
| BARON, J | 1 |
| SEARCY, RL | 1 |
| CRAIG, RG | 1 |
| GIDDINGS, JA | 1 |
| BERGQUIST, LM | 1 |
| PRIOR, IA | 1 |
| CAMPBELL, DG | 1 |
| FELDMAN, EB | 1 |
| CARTER, AC | 1 |
| MUELLER, J | 1 |
| ALSLEBEN, U | 1 |
| Jublanc, C | 1 |
| Bruckert, E | 4 |
| Giral, P | 4 |
| Chapman, MJ | 1 |
| Leenhardt, L | 1 |
| Carreau, V | 1 |
| Turpin, G | 4 |
| HERTZ, R | 1 |
| SCHRICKER, JA | 1 |
| TULLNER, WW | 1 |
| Al-Tonsi, AA | 1 |
| Abdel-Gayoum, AA | 1 |
| Saad, M | 1 |
| Parra, MD | 1 |
| Bernal, LJ | 1 |
| Cerón, JJ | 1 |
| Landén, M | 1 |
| Baghaei, F | 1 |
| Rosmond, R | 1 |
| Holm, G | 1 |
| Björntorp, P | 1 |
| Eriksson, E | 1 |
| Földes, J | 1 |
| Bános, C | 1 |
| Winkler, G | 1 |
| Park, JR | 1 |
| Jung, TS | 1 |
| Jung, JH | 1 |
| Lee, GW | 1 |
| Kim, MA | 1 |
| Park, KJ | 1 |
| Kim, DR | 1 |
| Chang, SH | 1 |
| Chung, SI | 1 |
| Hahm, JR | 1 |
| Tokinaga, K | 1 |
| Oeda, T | 1 |
| Suzuki, Y | 1 |
| Matsushima, Y | 1 |
| Assaf, C | 1 |
| Bagot, M | 1 |
| Dummer, R | 1 |
| Duvic, M | 1 |
| Gniadecki, R | 1 |
| Knobler, R | 1 |
| Ranki, A | 1 |
| Schwandt, P | 2 |
| Whittaker, S | 1 |
| Kiya, Y | 1 |
| Miura, S | 1 |
| Zhang, B | 1 |
| Urata, H | 1 |
| Saku, K | 1 |
| Asvold, BO | 1 |
| Vatten, LJ | 1 |
| Nilsen, TI | 1 |
| Bjøro, T | 1 |
| Hollander, CS | 1 |
| Thompson, RH | 1 |
| Barrett, PV | 1 |
| Berlin, NI | 1 |
| Tamási, G | 1 |
| Borsy, J | 1 |
| Patthy, A | 1 |
| Miettinen, TA | 1 |
| Carter, JK | 1 |
| Smith, RE | 1 |
| Chaudhuri, BN | 1 |
| Mukherjee, SK | 1 |
| Mongia, SS | 1 |
| Chakravarty, SK | 1 |
| Berdanier, CD | 1 |
| Ying, C | 1 |
| Miyada, D | 1 |
| Gwinup, G | 1 |
| Simpkins, H | 1 |
| Laskarzewski, P | 1 |
| Kelly, KA | 1 |
| Mellies, MJ | 1 |
| Morrison, JA | 1 |
| Khoury, P | 1 |
| Tillett, S | 1 |
| Glueck, CJ | 2 |
| Diekman, T | 1 |
| Lansberg, PJ | 1 |
| Kastelein, JJ | 1 |
| Wiersinga, WM | 1 |
| Petrasch, SG | 1 |
| Mlynek-Kersjes, ML | 1 |
| Haase, R | 1 |
| Benker, G | 1 |
| Olbricht, T | 1 |
| Paar, D | 1 |
| Reinwein, D | 1 |
| Shakir, KM | 1 |
| Kroll, S | 1 |
| Aprill, BS | 1 |
| Drake, AJ | 1 |
| Eisold, JF | 1 |
| Koshiyama, H | 1 |
| Koh, T | 1 |
| Sone, T | 1 |
| Surks, MI | 1 |
| Ocampo, E | 1 |
| Petersen, CE | 1 |
| Ha, CE | 1 |
| Jameson, DM | 1 |
| Bhagavan, NV | 1 |
| Lang, JE | 1 |
| Wang, P | 1 |
| Mariotti, S | 1 |
| Cabula, R | 1 |
| Petrini, L | 1 |
| Caradonna, A | 1 |
| Mercuro, G | 1 |
| Cherchi, A | 1 |
| Lindsay, RS | 1 |
| Toft, AD | 1 |
| Chadarevian, R | 3 |
| Ankri, A | 1 |
| Beucler, I | 1 |
| Helfand, M | 1 |
| Redfern, CC | 1 |
| Lucena, R | 1 |
| Moreno, P | 1 |
| Pérez-Rico, A | 1 |
| Ginel, PJ | 1 |
| Tsimihodimos, V | 1 |
| Bairaktari, E | 1 |
| Tzallas, C | 1 |
| Miltiadus, G | 1 |
| Liberopoulos, E | 2 |
| Elisaf, M | 2 |
| Miltiadous, G | 1 |
| Chu, JW | 1 |
| Crapo, LM | 1 |
| Efstathiadou, Z | 1 |
| Bitsis, S | 1 |
| Milionis, HJ | 1 |
| Kukuvitis, A | 1 |
| Bairaktari, ET | 1 |
| Elisaf, MS | 1 |
| Tsatsoulis, A | 1 |
| Jorde, R | 1 |
| Ryan, JR | 1 |
| Miyamoto, M | 1 |
| Inoue, K | 1 |
| Kojima, T | 1 |
| Nagashima, N | 1 |
| Ban, Y | 2 |
| Halawa, B | 1 |
| Mazurek, W | 1 |
| Schwartzkopff, W | 3 |
| Russ, E | 2 |
| Rogers, WA | 1 |
| Donovan, EF | 1 |
| Kociba, GJ | 1 |
| Lewith, G | 1 |
| Gabriel, R | 1 |
| Simons, LA | 1 |
| Myant, NB | 1 |
| Eaton, RP | 1 |
| Crespin, S | 1 |
| Kipnis, DM | 1 |
| Patsch, JR | 1 |
| Patsch, W | 1 |
| Sailer, S | 3 |
| Braunsteiner, H | 1 |
| Hempel, RD | 1 |
| Müller, G | 2 |
| Burchardt, U | 1 |
| Ballantyne, FC | 1 |
| Epenetos, AA | 1 |
| Caslake, M | 1 |
| Forsythe, S | 1 |
| Ballantyne, D | 1 |
| Kopp, H | 1 |
| Knüchel, F | 1 |
| Mertz, DP | 1 |
| Ciświcka-Sznajderman, M | 1 |
| Howard, AN | 1 |
| Mishkel, MA | 1 |
| Crowther, SM | 1 |
| Wahlqvist, ML | 1 |
| Fidge, NH | 1 |
| Lomas, F | 1 |
| Hazzard, WR | 1 |
| Rakow, AD | 1 |
| Klor, HU | 1 |
| Kuter, E | 1 |
| Ditschuneit, HH | 1 |
| Ditschuneit, H | 2 |
| Jackson, P | 1 |
| Lees, S | 1 |
| Pow, M | 1 |
| Willing, GW | 1 |
| Watson, D | 1 |
| Gless, KH | 1 |
| Oster, P | 1 |
| Hüfner, M | 1 |
| Parsons, WB | 1 |
| Kubasta, M | 1 |
| Vaverková, H | 1 |
| Beaumont, V | 1 |
| Margolis, S | 2 |
| Haacke, H | 1 |
| Kolenda, KD | 1 |
| Lee, DE | 1 |
| Lamb, SV | 1 |
| Reimers, TJ | 1 |
| Isichei, UP | 1 |
| Das, SC | 1 |
| Egbuta, JO | 1 |
| Kessler, AC | 1 |
| Rudorff, KH | 1 |
| Oellerich, M | 1 |
| Horn, K | 1 |
| Mattersberger, J | 1 |
| Hesch, RD | 1 |
| LaFranchi, S | 1 |
| Hanna, CE | 1 |
| Illingworth, DR | 1 |
| Sato, R | 1 |
| Kushima, K | 1 |
| Hara, H | 1 |
| Nagakura, H | 1 |
| Kumaoka, S | 1 |
| Emmrich, R | 1 |
| Guerre, J | 1 |
| Fredrickson, DS | 1 |
| von Löwis of Menar, P | 1 |
| Klemens, UH | 1 |
| Manning, PJ | 1 |
| Corwin, LA | 1 |
| Middleton, CC | 1 |
| Levy, RI | 2 |
| Rifking, BM | 1 |
| Morganroth, J | 1 |
| Rifkind, BM | 1 |
| Vastesaeger, M | 1 |
| Blaton, V | 1 |
| Declercq, B | 1 |
| Vercruysse, J | 1 |
| Vandamme, D | 1 |
| Peeters, H | 1 |
| Mortelmans, J | 1 |
| Albrink, MJ | 1 |
| Bybee, DE | 1 |
| Hamilton, RD | 1 |
| Edwards, KD | 2 |
| Schlierf, G | 1 |
| Michajlik, A | 1 |
| Sirtori, C | 1 |
| Fumagalli, R | 1 |
| Paoletti, R | 2 |
| Howe, R | 1 |
| Davis, PJ | 1 |
| Hsu, TH | 1 |
| Bianchine, JR | 1 |
| Morgan, JP | 1 |
| DePalma, RG | 1 |
| Insull, W | 1 |
| Bellon, EM | 1 |
| Roth, WT | 1 |
| Robinson, AV | 1 |
| Felt, V | 1 |
| Strasek, J | 1 |
| Bednár, J | 1 |
| Bommer, J | 1 |
| Ehrke, V | 1 |
| Speders, H | 1 |
| Baum, D | 1 |
| Guthrie, R | 1 |
| Brunzell, JD | 1 |
| Vogel, WC | 1 |
| Bierman, EL | 1 |
| Parwaresch, MR | 1 |
| Mäder, C | 1 |
| Hill, W | 1 |
| Wiswedel, K | 1 |
| Mlotowski, T | 1 |
| Wermut, W | 1 |
| Rynkiewicz, H | 1 |
| Szutowicz, A | 1 |
| Crepaldi, G | 1 |
| Fellin, R | 1 |
| Briani, G | 1 |
| Huth, K | 1 |
| Blumenthal, J | 1 |
| Schmahl, FW | 1 |
| Yoshitoshi, Y | 1 |
| Naito, C | 1 |
| Parker, F | 1 |
| Short, JM | 1 |
| Yamazaki, H | 1 |
| Nanbu, S | 1 |
| Gomes, MM | 1 |
| Bernatz, PE | 1 |
| Kottke, BA | 1 |
| Juergens, JL | 1 |
| Titus, JL | 1 |
| Gillman, J | 1 |
| Gilbert, C | 1 |
| Schurr, PE | 1 |
| Schultz, JR | 1 |
| Parkinson, TM | 1 |
| Likoff, W | 1 |
| LaRosa, JC | 1 |
| Lewis, M | 1 |
| Iammarino, RM | 1 |
| Irsigler, K | 1 |
| Flegel, U | 1 |
| Avogaro, P | 1 |
| Capri, C | 1 |
| Cazzolato, G | 1 |
| Pometta, D | 1 |
| Usardi, MM | 1 |
| Galli, C | 1 |
| Strisower, EH | 3 |
| Adamson, G | 2 |
| Strisower, B | 2 |
| Wagner, A | 1 |
| Maha, GE | 1 |
| Mazzei, ES | 1 |
| Mazzei, CM | 1 |
| Gotelli, C | 1 |
| Chiche, P | 1 |
| Chekler, P | 1 |
| Ribadeau-Dumas, JL | 1 |
| Derrida, R | 1 |
| Serio, M | 1 |
| Zilli, A | 1 |
| Tinti, P | 1 |
| Raspa, G | 1 |
| Steger, H | 1 |
| Schettler, G | 1 |
| Baker, BM | 1 |
| Porte, D | 2 |
| O'Hara, DD | 2 |
| Williams, RH | 2 |
31 reviews available for thyroxine and Hyperlipemia
| Article | Year |
|---|---|
Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis.
Topics: Blood Pressure; Carotid Intima-Media Thickness; Humans; Hyperlipidemias; Hypertension; Hypothyroidis | 2017 |
Thyroid hormones: a potential ally to LDL-cholesterol-lowering agents.
Topics: Cholesterol, LDL; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; | 2016 |
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature.
Topics: Antineoplastic Agents; Azetidines; Bexarotene; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Co | 2008 |
Effects of subclinical hypothyroidism and its treatment on serum lipids.
Topics: Humans; Hyperlipidemias; Hypothyroidism; Lipids; Thyroxine | 2003 |
[Subclinical hypothyroidism and arteriosclerosis].
Topics: Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Humans; Hyperlipidemias; Hypothyroidism; Lipid | 2004 |
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion.
Topics: Anticarcinogenic Agents; Bexarotene; Humans; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; | 2006 |
Effects of hypolipidemic drugs on bile acid metabolism in man.
Topics: Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fiber; Feces; Hum | 1981 |
[The heart and hypothyroidism].
Topics: Arteriosclerosis; Autoimmunity; Cardiovascular System; Echocardiography; Exercise Test; Heart Diseas | 1995 |
Hypothyroidism.
Topics: Humans; Hyperlipidemias; Hypothyroidism; Thyrotropin; Thyroxine | 1997 |
Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians.
Topics: Adult; Cost of Illness; Female; Humans; Hyperlipidemias; Hyperthyroidism; Hypothyroidism; Mass Scree | 1998 |
The treatment of subclinical hypothyroidism is seldom necessary.
Topics: Adult; Aged; Arteriosclerosis; Female; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypothy | 2001 |
["Subclinical" thyroid disease].
Topics: Cardiovascular Diseases; Diagnosis, Differential; Humans; Hyperlipidemias; Hypothyroidism; Risk Fact | 2002 |
Biochemical anomalies of the nephrotic syndrome.
Topics: Animals; Carbohydrate Metabolism; Cholesterol; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; | 1975 |
[Familial hyperlipoproteinemia type III].
Topics: Age Factors; Cholesterol; Chylomicrons; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipo | 1976 |
[Pharmacological treatment of primary hyperlipoproteinemia].
Topics: Cholesterol; Clofibrate; Depression, Chemical; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipopr | 1976 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise | 1975 |
A physician's guide to hyperlipidemia.
Topics: Adult; Cholesterol; Chylomicrons; Clofibrate; Diabetes Complications; Diet Therapy; Female; Humans; | 1972 |
Dietary and drug treatment of primary hyperlipoproteinemia.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; | 1972 |
Lipid lowering drugs and hyperlipidaemia.
Topics: Biological Transport; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; | 1973 |
Treatment of hyperlipidemia.
Topics: Blood Proteins; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Costs and Cost Analysis | 1974 |
Dietary and drug treatment of hyperlipidemia in diabetes.
Topics: Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diabetes M | 1974 |
The primary hyperlipoproteinemias.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Humans; Hyperc | 1974 |
Antilipaemic drugs and nephrotic hyperlipidaemia.
Topics: Alkenes; Animals; Blood Protein Disorders; Blood Proteins; Butyrates; Clofibrate; Humans; Hyperchole | 1972 |
[Hiperlipidemia as a risk factor in coronary artery disease].
Topics: Age Factors; Blood Protein Disorders; Cholesterol; Clofibrate; Coronary Disease; Diet Therapy; Human | 1973 |
Hypolipidemic drugs.
Topics: Aminosalicylic Acids; Androgens; Bile Acids and Salts; Butyrates; Cellulose; Cholestyramine Resin; C | 1973 |
Hypolipidaemic agents.
Topics: Androgens; Anticholesteremic Agents; Bile Acids and Salts; Chlorobenzenes; Clofibrate; Estrogens; Gl | 1974 |
[Cause of hyperlipemia in nephrotic syndrome].
Topics: Animals; Arteriosclerosis; Cholesterol; Fatty Acids, Nonesterified; Glycogen; Humans; Hyperlipidemia | 1968 |
Xanthomatosis associated with hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Chylomicrons; Clofibrate; D | 1970 |
[Recent advances in biochemistry in clinical pathology].
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Animals; Arteriosclerosis; Blood Protein Electrophoresis; | 1971 |
[Therapy of hyperlipidemia].
Topics: Alkenes; Animals; Arteriosclerosis; Cholesterol; Clofibrate; Diet Therapy; Fatty Acids; Humans; Hype | 1971 |
Ileal bypass in treatment of hyperlipidemia: rationale and present status.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Haplorhini; | 1970 |
9 trials available for thyroxine and Hyperlipemia
| Article | Year |
|---|---|
Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease.
Topics: Aged; Female; Follow-Up Studies; Heart Diseases; Humans; Hyperlipidemias; Logistic Models; Male; Mid | 2003 |
Nicotinic acid decreases serum thyroid hormone levels while maintaining a euthyroid state.
Topics: Adult; Female; Humans; Hyperlipidemias; Liver; Liver Function Tests; Male; Middle Aged; Niacin; Thyr | 1995 |
Relationship between thyroid hormones and plasma D-dimer levels.
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Biomarkers; Blood Coagulation; Confounding Factors, Epide | 1998 |
The metabolic spectrum of halofenate.
Topics: Blood Glucose; Cholesterol; Clinical Trials as Topic; Clofibrate; Creatine Kinase; Glycolates; Halof | 1975 |
[D-thyroxin in the therapy of type IIa and IIb hyperlipoproteinemias].
Topics: Adult; Aged; Cholesterol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, | 1977 |
[Clinical experience with etiroxate hydrochloride in patients with primary hyperlipoproteinemia].
Topics: Cholesterol; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Male; Placebos; Thyroxine; T | 1977 |
Hypolipaemic drugs and coronary heart disease.
Topics: Adult; Aged; Anion Exchange Resins; Cholesterol; Clinical Trials as Topic; Clofibrate; Coronary Dise | 1975 |
[Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Female; Heart; Heart Diseases; Humans; Hyperlipi | 1975 |
[Effect of highly purified D-thyroxine ("Dyno") in hyperlipoproteinemias type II a and II b].
Topics: Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Placebo | 1972 |
110 other studies available for thyroxine and Hyperlipemia
| Article | Year |
|---|---|
Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo.
Topics: Adipose Tissue, Brown; Animals; Energy Metabolism; Female; Fibroblast Growth Factors; Gene Expressio | 2014 |
Diabetic lipemia presenting as eruptive xanthomas in a child with autoimmune polyglandular syndrome type IIIa.
Topics: Child; Diabetes Mellitus, Type 1; Female; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypothyroidi | 2014 |
[Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Chol | 2016 |
Effects of serum indices interference on hormonal results from the Abbott Architect i2000 immunoassay analyser.
Topics: alpha-Fetoproteins; Carcinoembryonic Antigen; Chorionic Gonadotropin, beta Subunit, Human; Ferritins | 2015 |
Serum levels of thyroid hormones and thyroid stimulating hormone in patients with biliogenic and hyperlipidaemic acute pancreatitis: Difference and value in predicting disease severity.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bile Ducts; Biomarkers; Female; Humans; Hyperlipidemi | 2016 |
An unusual case of stroke.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diuretics; Female; Furo | 2012 |
[Thyroxin and total lipemia].
Topics: Humans; Hyperlipidemias; Lipids; Thyroxine | 1958 |
Some observations on the relationships between atherosclerosis, hyperlipemia, and D-thyroxine.
Topics: Arteriosclerosis; Atherosclerosis; Cholesterol; Dextrothyroxine; Estrogens; Humans; Hyperlipidemias; | 1962 |
[Treatment of hypercholesteremia, hyperlipemia and tuberous xanthomatosis with D-thyroxin].
Topics: Humans; Hypercholesterolemia; Hyperlipidemias; Thyroxine; Xanthomatosis | 1963 |
Effects of sulfonylurea compounds on hyperlipemia and hypercholesteremia in patients with minimal impairment of glucose tolerance.
Topics: Carbohydrate Metabolism; Diabetes Mellitus; Glucose; Humans; Hypercholesterolemia; Hyperlipidemias; | 1962 |
[Protective action of D-thyroxin on disorders of ocular vascularization induced in the rabbit by an experimental hypercholesterolemic hyperlipemia].
Topics: Animals; Eye; Hypercholesterolemia; Hyperlipidemias; Neovascularization, Pathologic; Rabbits; Retina | 1963 |
Treatment of hyperlipemic diabetic patients. Effects of dextro-thyroxine therapy.
Topics: Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypoglycemi | 1963 |
THE EFFECT OF ATROMID, AN ORALLY ACTIVE ANDROSTERONE ON SERUM LIPIDS IN NORMAL, HYPERCHOLESTEROLAEMIC AND HYPERLIPAEMIC SUBJECTS.
Topics: Androsterone; Aspartate Aminotransferases; Cholesterol; Clofibrate; Glycerides; Humans; Hypercholest | 1963 |
REDUCTION OF SERUM TRIGLYCERIDES IN PATIENTS TREATED WITH SODIUM D-THYROXINE.
Topics: Blood Chemical Analysis; Child; Dextrothyroxine; Glycerides; Hypercholesterolemia; Hyperlipidemias; | 1963 |
[ON THE CLINICAL ASPECTS AND THERAPY OF HYPERLIPEMIA].
Topics: Arteriosclerosis; Cholesterol; Diabetes Mellitus; Diagnosis, Differential; Dietary Fats; Fatty Acids | 1964 |
Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Humans; Hyperlipidemias; Middle Aged; Radio | 2004 |
Dietary and dosage factors affecting thyroxine inhibition of estrogen-induced lipemia in the chick.
Topics: Animals; Chickens; Diet; Estrogens; Humans; Hyperlipidemias; Lipids; Thyroxine | 1951 |
The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders.
Topics: Cholesterol; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hyperlipidemias; Middle Aged; Phosph | 2004 |
Cortisol and free thyroxine determination by time-resolved fluorometry in canine serum.
Topics: Animals; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Fluorometry; Hemolysis; Huma | 2004 |
Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety.
Topics: Adult; Anxiety Disorders; Body Constitution; Body Mass Index; Cohort Studies; Comorbidity; Female; H | 2004 |
A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas.
Topics: Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Female; Fenofibrate; Humans; Hyperlipidemias; Hy | 2005 |
HMG-CoA reductase inhibitors (statins) might cause high elevations of creatine phosphokinase (CK) in patients with unnoticed hypothyroidism.
Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholesterol, HDL; Contraindications; Creati | 2006 |
Effect of levothyroxine on total lipid profiles as assessed by analytical capillary isotachophoresis in a patient with hypothyroidism.
Topics: Electrophoresis, Capillary; Female; Humans; Hyperlipidemias; Hypothyroidism; Lipids; Lipoproteins; M | 2006 |
The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study.
Topics: Adult; Age Distribution; Aged; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studi | 2007 |
Repair of the anemia and hyperlipidemia of the hypothyroid dog.
Topics: Anemia; Animals; Blood Proteins; Blood Volume; Body Weight; Calorimetry; Dinitrophenols; Dogs; Eryth | 1967 |
Effects of 3-carboxyl-5-methylpyrazole (CMP) on serum and liver lipids in rats.
Topics: Animals; Fatty Acids, Nonesterified; Heparin; Hyperlipidemias; Liver; Male; Nicotinic Acids; Pyrazol | 1967 |
Specificity of avian leukosis virus-induced hyperlipidemia.
Topics: Animals; Avian Leukosis Virus; Body Weight; Chick Embryo; Chickens; Hyperlipidemias; Insulin; Liver; | 1984 |
Hypolipidemic effect of garlic and thyroid function.
Topics: Animals; Cholesterol, Dietary; Dietary Fats; Female; Garlic; Hyperlipidemias; Iodides; Lipids; Male; | 1984 |
Effects of thyroid hormone on the gluconeogenic capacity of lipemic BHE rats.
Topics: Animals; Gluconeogenesis; Hyperlipidemias; In Vitro Techniques; Kinetics; Liver; Male; Rats; Rats, I | 1983 |
Effect of hyperlipidemia on homogeneous enzyme immunoassay for thyroxine.
Topics: Glucosephosphate Dehydrogenase; Humans; Hyperlipidemias; Immunoenzyme Techniques; Lipids; Malate Deh | 1981 |
Clinical chemistry determinations for a biracial cohort of 1,605 normal and hyperlipidemic schoolchildren aged 6 to 17.
Topics: Adolescent; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Child; Crea | 1980 |
Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia.
Topics: Aged; Cholesterol, LDL; Female; Follow-Up Studies; Humans; Hyperlipidemias; Hypothyroidism; Lipids; | 1995 |
Basophilic leukocytes in hypothyroidism.
Topics: Adult; Aged; Aged, 80 and over; Basophils; Cholesterol; Humans; Hyperlipidemias; Hypothyroidism; Leu | 1993 |
Therapeutic dilemma with thyroxine replacement in hypothyroidism.
Topics: Bone Density; Cholesterol; Humans; Hyperlipidemias; Hypothyroidism; Thyroxine | 1994 |
Subclinical thyroid disease.
Topics: Heart; Humans; Hyperlipidemias; Hyperthyroidism; Hypothyroidism; Thyroid Function Tests; Thyrotropin | 1996 |
Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia.
Topics: Binding Sites; Humans; Hyperlipidemias; Hyperthyroxinemia; Recombinant Proteins; Serum Albumin; Thyr | 1996 |
Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism.
Topics: Aged; Anticholesteremic Agents; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gemfibrozil; Huma | 1996 |
Effects of haemolysis, lipaemia and bilirubinaemia on an enzyme-linked immunosorbent assay for cortisol and free thyroxine in serum samples from dogs.
Topics: Animals; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Hemolysis; Hydrocortisone; Hyperbili | 1998 |
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic.
Topics: Dose-Response Relationship, Drug; Fasting; Female; Humans; Hyperlipidemias; Hypothyroidism; Incidenc | 1999 |
Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients.
Topics: Adult; Aged; Arteriosclerosis; Carotid Stenosis; Humans; Hyperlipidemias; Male; Middle Aged; Risk Fa | 1999 |
Relationship between thyroid hormones and fibrinogen levels.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Midd | 1999 |
Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Fibric Acids; Humans; Hyperlipidemias; Hyperthyr | 2001 |
Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
Topics: Adult; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hyperlipi | 2001 |
[Effects of halofenate on thyroxine-binding globulin (TBG) and thyroid function tests using TBG].
Topics: Adult; Aged; Alpha-Globulins; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle | 1976 |
[Serum levels of thyrotropin triiodothyronine, thyroxine and thyroxine-binding proteins in patients with coronary disease and hyperlipoproteinemia of the IIA and IIB types].
Topics: Coronary Disease; Humans; Hyperlipidemias; Middle Aged; Thyrotropin; Thyroxine; Thyroxine-Binding Pr | 1979 |
[Long-term treatment of hyperlipoproteinaemia, types IIa and IIb, with etiroxate (author's transl)].
Topics: Adult; Aged; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipoprotein | 1975 |
Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoproteinemia.
Topics: Animals; Cholesterol; Diabetes Complications; Diabetes Mellitus; Dog Diseases; Dogs; Female; Glycero | 1975 |
Cholesterol metabolism in hypertriglyceridaemia and the effects of treatment.
Topics: Adult; Alcohol Drinking; Bile Acids and Salts; Cholesterol; Chylomicrons; Diabetes Complications; Di | 1975 |
Incorporation of 75Se-selenomethionine into human apoproteins. III. Kinetic behavior of isotopically labeled plasma apoprotein in man.
Topics: Adult; Amino Acids; Apoproteins; Heparin; Humans; Hyperlipidemias; Kinetics; Lipoproteins, LDL; Lipo | 1976 |
The composition of low-density lipoprotein and very-low-density lipoprotein subfractions in primary hypothyroidism and the effect of hormone-replacement therapy.
Topics: Aged; Cholesterol; Female; Humans; Hyperlipidemias; Hypothyroidism; Lipoproteins, LDL; Lipoproteins, | 1979 |
[Therapy of disorders of the lipid metabolism which carry the risk of arteriosclerosis].
Topics: Adult; Body Weight; Drug Evaluation; Female; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Thy | 1978 |
[Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Germany, West; Humans; Hyperlipidemias; Hypolipidemic | 1979 |
Hypothyroidism, an important cause of reversible hyperlipidemia.
Topics: Adolescent; Adult; Aged; Cholesterol; Female; Humans; Hyperlipidemias; Hypothyroidism; Lipids; Male; | 1977 |
Lipoprotein composition in hypothyroidism.
Topics: Adolescent; Adult; Aged; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypothy | 1977 |
[Hyperlipidemias. Diet and drug therapy].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine | 1977 |
A pathophysiologic approach to managing hyperlipemia.
Topics: Adult; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyperlipidemias; Lipid Me | 1976 |
Treatment of type II hyperlipoproteinemia with d-thyroxine.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Cholesterol; Cr | 1976 |
Radioimmunoassay kits for thyroid hormones.
Topics: Blood Proteins; Costs and Cost Analysis; Female; Humans; Hyperlipidemias; Hypothyroidism; Pregnancy; | 1976 |
[TSH-secretion, thyroxine- and triiodothyronine concentrations under D-thyroxine administration].
Topics: Humans; Hyperlipidemias; Hypothyroidism; Thyrotropin; Thyroxine; Triiodothyronine | 1976 |
Hyperlipidemia: to treat or not to treat.
Topics: Cerebrovascular Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Female; Humans; Hyper | 1975 |
[Hyperlipoproteinemias in internal medicine and therapeutic possibilities].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine | 1975 |
[Treatment of hyperlipemia. III. Practical modalities].
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Heparin; Humans; Hyperlipidemias; Nicotinic Acids; Thyr | 1975 |
The hyperlipoproteinemias in adolescence.
Topics: Adolescent; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Dietary Carbohydrates; Dietary F | 1975 |
[Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
Topics: Cholestyramine Resin; Clofibrate; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipidem | 1976 |
Effects of hyperlipemia on radioimmunoassays for progesterone, testosterone, thyroxine, and cortisol in serum and plasma samples from dogs.
Topics: Animals; Dog Diseases; Dogs; Fat Emulsions, Intravenous; Female; Gonadal Steroid Hormones; Hydrocort | 1991 |
Central cretinism in four successive siblings.
Topics: Adolescent; Child; Congenital Hypothyroidism; Female; Humans; Hyperlipidemias; Male; Thyrotropin; Th | 1990 |
[Methods and clinical evaluation of a new enzyme immunologic method for determination of thyroxin binding globulin (TBG) and T4/TBG quotient: a multicenter study].
Topics: Anticoagulants; Chromatography, Gel; Chromatography, Ion Exchange; Hemolysis; Humans; Hyperbilirubin | 1985 |
Effect of growth hormone replacement on development of hypothyroidism and hyperlipidemia.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Creatine Kinase; Female; Growth; Growth Hormone; H | 1985 |
[Effect of hyperlipidemia on the free thyroxine value by radioimmunoassay].
Topics: Adult; Aged; Aging; Female; Humans; Hyperlipidemias; Male; Middle Aged; Radioimmunoassay; Reagent Ki | 1985 |
Long-term administration of 3,5-diodo-4(3'-iodo4'-acetoxyphenoxy) benzoic acid (acetiromate) in hyperlipidemic patients.
Topics: Aged; Cholesterol; Drug Evaluation; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Iodobenzo | 1974 |
[Therapy of arteriosclerosis].
Topics: Anticholesteremic Agents; Anticoagulants; Arteriosclerosis; Cholesterol; Choline; Diabetes Complicat | 1968 |
[Hyperlipemias].
Topics: Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Sterols; Thyroxine | 1965 |
[Therapy of hyperlipoproteinemias type II a and II b using dextro-thyroxine or D,L-alpha-methyl-thyroxine-ethylester].
Topics: Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Thyroid | 1972 |
Familial hyperlipoproteinemia and thyroid dysfunction of beagles.
Topics: Aging; Animals; Cholesterol; Dogs; Electrophoresis; Glucose Tolerance Test; Glycerides; Humans; Hype | 1973 |
Comparative treatment of hyperlipoproteinaemias in chimpanzees.
Topics: Animals; Cholesterol; Clofibrate; Diet, Atherogenic; Fatty Acids; Female; Hyperlipidemias; Lipoprote | 1974 |
The influence of drugs affecting lipids on atherosclerosis.
Topics: Adult; Arteriosclerosis; Blood Protein Disorders; Clofibrate; Coronary Disease; Diabetes Complicatio | 1974 |
[What is assured in the treatment of hyperlipemia?].
Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Nicotinic Acids; Thyroxine; | 1972 |
Effects of a new hypolipidemic agents, MK-185, on serum thyroxine-binding globulin (TBG) and dialyzable fraction thyroxine.
Topics: Animals; Binding Sites; Blood Protein Electrophoresis; Carbon Isotopes; Cattle; Dialysis; Glycolates | 1972 |
Animal models for the study of progression and regression of atherosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Coronary | 1972 |
[Index of "unbound" thyroxine in patients with hypercholesterolemia or hypertriglyceridemia treated with clofibrate].
Topics: Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Thyroxine; Thy | 1972 |
[Preliminary results of hyperlipemia therapy using a new D-thyroxine preparation].
Topics: Adult; Aged; Cholesterol; Female; Humans; Hyperlipidemias; Male; Methods; Middle Aged; Thyroxine | 1972 |
Triglyceride abnormality in infantile hypothyroidism.
Topics: Cholesterol; Chylomicrons; Congenital Hypothyroidism; Humans; Hyperlipidemias; Hypothyroidism; Infan | 1973 |
[Experimental induction of atherosclerosis in rabbits by a combined method].
Topics: Animals; Aorta; Arteriosclerosis; Calcinosis; Catecholamines; Cholesterol; Diet, Atherogenic; Hyperl | 1973 |
[Familial hyperlipoproteinemia and its treatment].
Topics: Aged; Female; Humans; Hyperlipidemias; Male; Middle Aged; Pedigree; Thyroxine | 1973 |
Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
Topics: Adolescent; Adult; Alcohol Drinking; Body Weight; Child; Cholesterol, Dietary; Cholestyramine Resin; | 1973 |
[Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Lipoproteins; | 1973 |
[Hyperlipoproteinemias: significance--diagnosis--therapy].
Topics: Adolescent; Adult; Blood Protein Disorders; Cardiovascular Diseases; Child; Child, Preschool; Choles | 1971 |
Some aspects of the endocrine control of the serum lipids, blood ketones and blood sugar in fed and fasted baboons, and of the mechanism of fuel control in fasting, with special reference to diabetes and lipaemia.
Topics: Adrenalectomy; Animals; Blood Glucose; Carbohydrate Metabolism; Castration; Cortisone; Diabetes Mell | 1970 |
Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.
Topics: Animals; Carboxylic Acids; Cholesterol; Clofibrate; Disease Models, Animal; Fasting; Hyperlipidemias | 1972 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Die | 1972 |
Hyperlipoproteinemia. 3. Drug therapy.
Topics: Age Factors; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; Ethers, Cyclic; Humans; H | 1972 |
Lipemia in rodent iron-deficiency anemia.
Topics: Anemia, Hypochromic; Animals; Blood Transfusion; Cholesterol; Electrophoresis; Heparin; Hyperlipidem | 1971 |
[Antilipidemic agents].
Topics: Adult; Alcohols; Anticholesteremic Agents; Biguanides; Blood Protein Disorders; Body Weight; Cholest | 1971 |
[Therapy of hyperlipidemias].
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Estrogens; Glycine max; Heparin; Humans; Hyperlipidem | 1971 |
[New aspects of the therapy of arteriosclerosis].
Topics: Arteriosclerosis; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperlipidemias; Lipoprote | 1971 |
[Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners].
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Family Practice; Humans; Hypercholesterolemia; Hyperlip | 1970 |
Studies on the pharmacological control of hyperlipemia in experimental nephrotic syndrome.
Topics: Animals; Butyrates; Chemical and Drug Induced Liver Injury; Cholesterol; Cholestyramine Resin; Disea | 1970 |
Treatment of hyperlipidemic states.
Topics: Adult; Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; | 1970 |
[Treatment of hyperlipemias].
Topics: Cholesterol; Clofibrate; Diagnosis, Differential; Diet Therapy; Dietary Carbohydrates; Dietary Fats; | 1971 |
Diet and drug therapy for hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Body Weight; Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbo | 1971 |
[Effect of sodium d-thyroxine on the hiperlipedemia, hypercholesteremia, triglycerides and serum lipoproteins in patients with arteriosclerosis].
Topics: Arteriosclerosis; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Thyroxine; Triglyceri | 1967 |
[Antilipemics and atherosclerosis].
Topics: Adult; Aged; Arteriosclerosis; Arteritis; Cerebrovascular Disorders; Cholesterol; Coronary Disease; | 1967 |
[Therapeutic use of a new non-salified D-thyroxine (D-thyroxine acid)].
Topics: Adult; Aged; Anticholesteremic Agents; Female; Humans; Hyperlipidemias; Hypothyroidism; Iodine Radio | 1968 |
Treatment of hyperlipidemias.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Butyrates; Diet Therapy; Dietary Carbohydrates; D | 1968 |
[Studies on the effect of d-thyroxine in patients with increased serum lipid level].
Topics: Adult; Aged; Cholesterol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension, Malig | 1968 |
[Differentiation and drug therapy of lipemias].
Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Platelet Disorders; Carbohydrate Metabolism; Diagn | 1968 |
Control of coronary heart disease--treatment of hyperlipidemia.
Topics: Butyrates; Cholesterol; Coronary Disease; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Humans; | 1969 |
The relation between postheparin lipolytic activity and plasma triglyceride in myxedema.
Topics: Enzymes; Glycerides; Heparin; Humans; Hyperlipidemias; In Vitro Techniques; Lipids; Lipoprotein Lipa | 1966 |
The effect of diet and thyroxin on plasma lipids in myxedema.
Topics: Adult; Cholesterol; Diet; Glycerides; Humans; Hyperlipidemias; Lipids; Lipoproteins; Middle Aged; My | 1966 |
The combined use of CPIB and thyroxine in treatment of hyperlipoproteinemias.
Topics: Adult; Blood Protein Disorders; Butyrates; Dietary Carbohydrates; Drug Synergism; Female; Humans; Hy | 1966 |